CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 64 filers reported holding CHEMOCENTRYX INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,860,000 | -10.7% | 248,943 | -57.2% | 0.00% | 0.0% |
| Q2 2022 | $14,398,000 | -11.1% | 581,050 | -10.0% | 0.00% | 0.0% |
| Q1 2022 | $16,191,000 | -8.9% | 645,833 | +32.4% | 0.00% | 0.0% |
| Q4 2021 | $17,765,000 | -94.3% | 487,909 | -92.0% | 0.00% | -94.5% |
| Q1 2021 | $313,141,000 | -17.8% | 6,111,277 | -0.6% | 0.06% | -21.4% |
| Q4 2020 | $380,726,000 | +3.6% | 6,148,679 | -8.3% | 0.07% | -7.9% |
| Q3 2020 | $367,343,000 | +33.1% | 6,703,334 | +39.7% | 0.08% | +24.6% |
| Q2 2020 | $276,030,000 | +66573.9% | 4,797,171 | +14519.7% | 0.06% | – |
| Q3 2018 | $414,000 | -4.2% | 32,813 | 0.0% | 0.00% | – |
| Q2 2018 | $432,000 | -83.6% | 32,813 | -82.4% | 0.00% | -100.0% |
| Q2 2013 | $2,641,000 | – | 186,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,596,772 | $58,716,000 | 11.42% |
| WASATCH ADVISORS LP | 2,536,928 | $17,327,000 | 0.18% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,810,456 | $12,365,000 | 0.11% |
| BLUE ARROW CAPITAL MANAGEMENT LLC | 140,000 | $956,000 | 0.11% |
| Artal Group S.A. | 400,000 | $2,732,000 | 0.10% |
| Artal Group S.A. | 400,000 | $2,732,000 | 0.10% |
| Gruss Capital Management LP | 483,000 | $3,299,000 | 0.09% |
| Fernwood Investment Management, LLC | 10,000 | $68,000 | 0.06% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,276,833 | $8,721,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 120,000 | $820,000 | 0.02% |